证券之星消息，根据天眼查APP-财产线索数据整理，根据北京市海淀区心理康复医院12月7日发布的 《医疗服务体系智能化水平提升项目(海淀区心理康复医院)政府采购合同》内容显示，卫宁健康科技集 团股份有限公司中标，详情如下： 采购方：北京市海淀区心理康复医院 供应商：卫宁健康科技集团股份有限公司 中标金额：2165000.0 地区：北京市 发布日期：2025-12-07 数据来源：天眼查APP 以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成 投资建议。 标题：医疗服务体系智能化水平提升项目(海淀区心理康复医院)政府采购合同 通过天眼查大数据分析，卫宁健康科技集团股份有限公司共对外投资了50家企业，参与招投标项目 10095次；财产线索方面有商标信息124条，专利信息519条，著作权信息545条；此外企业还拥有行政许 可24个。 ...

证券之星消息，12月8日医疗信息化板块较上一交易日上涨0.81%，荣科科技领涨。当日上证指数报收于 3924.08，上涨0.54%。深证成指报收于13329.99，上涨1.39%。医疗信息化板块个股涨跌见下表： | 代码 | 名称 | 收盘价 | 涨跌幅 | 成交量(手) | 成交额(元) | | --- | --- | --- | --- | --- | --- | | 300290 | 荣科科技 | 31.50 | 20.00% | 56.27万 | 16.96亿 | | 301218 | 半島科技 | 25.13 | 12.64% | 19.10万 | 4.84亿 | | 002589 | 瑞康医药 | 4.69 | 10.09% | 551.02万 | 25.16 Z | | 300578 | 会畅通讯 | 19.14 | 6.87% | 13.86万 | 2.64亿 | | 300078 | 思创医惠 | 5.30 | 6.64% | 225.80万 | 11.76 Z | | 301248 | 杰创智能 | 29.95 | 6.55% | 16.15万 | 4.847 | | 300324 | 旋 ...

医学检查影像跨省调阅此前为何难以实现？国家医保局大数据中心副主任赵秀竹总结，核心在 于"阅不快""找不到""存不起""调不顺"四大难题——影像数据文件体积大，直接调阅速度慢，单独检索 某位患者的影像如同"大海捞针"；存储需建设专用信息基础设施，且要满足门诊影像保留15年、住院影 像保留30年的要求，持续的投资和维护成本带来"存不起"的压力；此外，不同医疗机构间缺乏统一平 台，系统兼容性差，直接对接调取效率低，导致"调不顺"。 "国家医保局推进全国医保影像云跨省调阅，已针对性解决上述问题。"付超奇介绍，全国医保统一 的信息平台覆盖全国100多万家定点医疗机构，覆盖全国超13亿参保人每年约100亿次看病就医购药行 为。今年，国家医保局出台医保影像云索引规则，为每份影像资料赋予78位全国统一编码，通过该编码 可以一键定位患者做检查的医院、时间及对应影像，彻底解决"找不着"问题；依托全国统一平台汇总各 地影像索引，"调不顺"的问题也同步化解。同时，医保定价政策明确，各地医保部门可以将影像本地存 储、跨地传输纳入数字化耗材集中采购范畴，无需地方财政额外投入，实现在医保体系内闭环推进。 医保影像跨省调阅后的信息安全问题， ...

本报讯 （记者矫月）近日，由深圳北理莫斯科大学、莫大-北理工-深北莫应用数学联合研究中心主办， 健康160国际有限公司（以下简称"健康160"）等单位协办的"AI+医疗数据引领大健康行业升级"会议在 深圳北理莫斯科大学成功举办。在会议中，健康160首次披露：其AI驱动医院运营升级方案已助力深圳 某医院实现年增收超5000万元。这一数字背后，是医疗数据要素化价值释放的冰山一角。 "医疗大数据作为第五大生产要素的价值释放窗口已经打开。"与会专家表示，在数据要素市场化配置改 革加速背景下，健康160等平台型企业将率先受益。 健康160集团总裁冀冉在主题演讲中系统展示了其独特的盈利模式。公司以医院微信公众号为数字化主 阵地，构建消费医疗、智慧导诊、医生品牌与院长数据驾驶舱四大模块，形成完整的公众号运营升级方 案，推动医院向数据驱动的精准运营转型。 在平台推广上，健康160依托"公众号私域+平台公域"双轮驱动模式，结合5500万用户数据与华为鸿蒙生 态入口，基于AI精准推荐为医院引流优质患者。这一模式不仅解决了医院在医保控费背景下的增收难 题，更开辟了可复制、可推广的数字化实践路径。 更值得关注的是，健康160已研发测 ...

证券日报网讯12月5日，荣科科技（300290）在互动平台回答投资者提问时表示，过去几年公司业绩承 压，主要受医疗信息化产业调整、项目交付及回款周期延长影响，同时公司坚持长期主义，持续加大研 发投入以巩固核心竞争力，短期内对利润造成了一定影响。当前公司正通过优化业务结构、强化回款管 理、提升运营效率等举措积极改善经营，全力推进此前提出的产业与资本协同战略。 ...

在近日举办的"AI+医疗数据引领大健康行业升级"会议上，健康160（2656.HK）首次披露：其AI驱动医 院运营升级方案已助力深圳某医院实现年增收超5000万元。这一数字背后，是医疗数据要素化价值释放 的冰山一角。 政策东风已至：医疗AI迎来黄金投资窗口 "医疗大数据作为第五大生产要素的价值释放窗口已经打开。"与会专家指出，在数据要素市场化配置改 革加速背景下，健康160等平台型企业将率先受益。 商业模式已验证：双轮驱动打造增收引擎 健康160集团总裁冀冉在主题演讲中系统展示了其独特的盈利模式。公司以医院微信公众号为数字化主 阵地，构建消费医疗、智慧导诊、医生品牌与院长数据驾驶舱四大模块，形成完整的公众号运营升级方 案，推动医院向数据驱动的精准运营转型。 在平台推广上，健康160依托"公众号私域+平台公域"双轮驱动模式，结合5500万用户数据与华为鸿蒙生 态入口，基于AI精准推荐为医院引流优质患者。这一模式不仅解决了医院在医保控费背景下的增收难 题，更开辟了可复制、可推广的数字化实践路径。 尽管医疗数据所有权归患者所有，但通过创新服务模式，健康160可合法为药企、保险机构等提供合规 数据服务，开辟全新营收渠 ...

Core Insights - Changzhou has launched a "digital intelligence" upgrade for resident health records, being the first in the province to implement a "one person, one file, one code" service, aimed at creating a comprehensive electronic health record for each resident [1][2] Group 1: Health Data Integration - The city has integrated health data from various medical institutions, resulting in the collection of 5 million resident health records, allowing citizens to access their complete medical history across public healthcare facilities [2][3] - Residents can easily query their health records through the "My Changzhou APP," enhancing the convenience of medical consultations [2][3] Group 2: Health Monitoring and Prevention - The new service includes a "health holographic portrait" feature that provides residents with insights into their health status and potential risk factors, enabling proactive health management [2][3] - The system offers personalized intervention suggestions based on big data analysis, shifting the focus from passive treatment to active prevention [2][3] Group 3: AI Integration - An AI digital assistant has been introduced to assist residents in analyzing their health status, interpreting medical reports, and managing chronic diseases, providing tailored advice on medication, diet, and lifestyle [3][4] - The AI digital assistant has been described as a "personal doctor," offering detailed explanations and customized follow-up plans to alleviate patient anxiety [3][4] Group 4: Privacy and Security - Residents have control over their privacy settings, allowing them to restrict access to their health records, which can be shared with healthcare providers through a scanning authorization process [3][4] Group 5: Future Developments - Changzhou plans to expand the "one person, one file, one code" service by incorporating more innovative features, including AI algorithms for comprehensive health management across prevention, screening, diagnosis, treatment, and rehabilitation [4]

Core Insights - The launch of the national medical insurance imaging cloud for cross-province retrieval marks the beginning of a new era in digital medical imaging, allowing for efficient and economical patient care [1][2][3] Group 1: Development and Implementation - The national medical insurance imaging cloud shared path was officially launched on December 1, 2022, with nearly 200 million medical imaging cloud index data collected from provinces within a year [1][2] - As of December 3, 2023, over 193 million medical imaging data have been uploaded for cross-province retrieval, demonstrating significant progress in data collection [3][5] - The initiative aims to eliminate the burden of repeated examinations for patients, with over 650 million cross-province medical settlements recorded during the 14th Five-Year Plan period [2][3] Group 2: Benefits and Impact - The imaging cloud enhances diagnostic accuracy and improves patient experience by allowing doctors to access historical imaging data remotely, thus reducing the need for patients to carry physical films [4][6] - The transition to cloud-based imaging is expected to save patients over 10 billion yuan annually by minimizing redundant examinations [5][6] - The unified coding and standardization of imaging data facilitate better integration and sharing of patient information across different healthcare institutions [8][9] Group 3: Industry Transformation - The national medical insurance imaging cloud represents a critical step towards breaking down information silos in the medical imaging industry, promoting full connectivity and interoperability [7][8] - The cloud platform allows for comprehensive integration of patient data, enabling healthcare providers to assess treatment efficacy and adjust care plans more effectively [8] - The initiative is anticipated to enhance the efficiency of medical services, allowing healthcare professionals to focus more on core treatment activities [8][9]

新京报讯（记者刘旭）11月28日，嘉和美康（北京）科技股份有限公司（以下简称嘉和美康）发布了一 份上交所的纪律处分决定书，因2022年及2023年财务报告存在会计差错导致信息披露不准确，上交所对 嘉和美康及时任董事长兼总经理夏军、时任财务负责人任勇予以通报批评。 作为医疗信息化产品及服务提供商，嘉和美康是国内最早从事医疗信息化软件研发与产业化的企业之 一，于2021年12月14日在上交所上市。据全球知名ICT（信息与通讯技术）市场信息咨询公司IDC今年7 月发布的《中国电子病历系统市场份额，2024：智能化再升级》，2024年，嘉和美康以15.0%的市场份 额，连续11年居行业第一。不过，近年来，嘉和美康业绩却并不理想，营收连续下滑，2024年陷入亏 损。 2022年-2024年及2025年前三季度，嘉和美康的营收分别为7.17亿元、6.95亿元、5.92亿元、3.3亿元，同 比变化幅度分别为9.97%、-3.04%、-14.85%、-30.67%；同期净利润分别为6458万元、3228万元、-2.56 亿元、-1.74亿元。 嘉和美康在2025年三季度报中表示，当前行业环境较为复杂，部分医院客户需求释放递延 ...

Core Viewpoint - The company Jiahe Meikang has faced significant financial corrections and disciplinary actions from the Shanghai Stock Exchange due to accounting errors that have led to substantial reductions in reported profits for 2022 and 2023 [2][3][4]. Financial Corrections - In April, Jiahe Meikang announced corrections to its financial reports, reducing the net profit for 2022 by 3.4463 million yuan, which is 8.46% of the original amount, and for 2023 by 10.213 million yuan, which is 50.35% of the original amount [2][3]. - The total profit adjustments for 2022 amounted to 4.0544 million yuan (14.81% reduction) and for 2023, 11.3478 million yuan (169.95% increase in losses) [3]. Disciplinary Actions - The Shanghai Stock Exchange issued a disciplinary notice, criticizing the company's former chairman and financial officer, and requiring the company to submit a rectification report within one month [4]. - The company has been instructed to improve its compliance and information disclosure practices [4]. Financial Performance - Jiahe Meikang reported a significant increase in losses, with a net profit of -256 million yuan for 2024, reflecting a year-on-year decline of 893.31% [5]. - The company’s revenue for the first half of the year was 219 million yuan, a decrease of 27.22% year-on-year, with net losses expanding to -116 million yuan, compared to -27.47 million yuan in the same period last year, marking a 323.29% increase in losses [6]. Market Position - Despite being recognized as the leading company in the electronic medical record market in China for eleven consecutive years, Jiahe Meikang's recent financial struggles contrast sharply with its market position [5]. - The company serves over 650 tertiary hospitals, accounting for more than one-third of such hospitals in the country, indicating its significant market presence [5].